Biblio Discovery — Demo Discovery Service

17 results for "Samrat, Subodh Kumar"

Showing 1–17 · 0.96 seconds · RSS

  1. Journal Article Full text

    Temporal Analysis of the Nuclear-to-cytoplasmic Translocation of a Herpes Simplex Virus 1 Protein by Immunofluorescent Confocal Microscopy

    Samrat, Subodh Kumar; Gu, Haidong

    J Vis Exp · 2018 · English · PubMed Central

    Infected cell protein 0 (ICP0) of herpes simplex virus 1 (HSV-1) is an immediate early protein containing a RING-type E3 ubiquitin ligase. It is responsible for the proteasomal degradation of host restrictive factors and the subsequent viral gene activation. ICP0 contains a canonical nuclear…

  2. Journal Article Full text

    A Tale of Two PMLs: Elements Regulating a Differential Substrate Recognition by the ICP0 E3 Ubiquitin Ligase of Herpes Simplex Virus 1

    Zheng, Yi; Samrat, Subodh Kumar; Gu, Haidong

    J Virol · 2016 · English · PubMed Central

    Infected cell protein 0 (ICP0) of herpes simplex virus 1 (HSV-1) is an α gene product required for viral replication at low multiplicities of infection. Upon entry, nuclear domain 10 (ND10) converges at the incoming DNA and represses viral gene expression. ICP0 contains a RING-type E3 ubiquitin…

  3. Journal Article Full text

    Characterization of Elements Regulating the Nuclear-to-Cytoplasmic Translocation of ICP0 in Late Herpes Simplex Virus 1 Infection

    Samrat, Subodh Kumar; Ha, Binh L.; Zheng, Yi et al.

    J Virol · 2018 · English · PubMed Central

    Infected cell protein 0 (ICP0) of herpes simplex virus 1 (HSV-1) is an immediate early protein containing a RING-type E3 ubiquitin ligase. It targets several host factors for proteasomal degradation and subsequently activates viral expression. ICP0 has a nuclear localization sequence and functions…

  4. Journal Article Full text

    Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development

    Samrat, Subodh Kumar; Tharappel, Anil M.; Li, Zhong et al.

    Virus Res · 2020 · English · PubMed Central

    The recent outbreak of the betacoronavirus SARS-CoV-2 has become a significant concern to public health care worldwide. As of August 19, 2020, more than 22,140,472 people are infected, and over 781,135 people have died due to this deadly virus. In the USA alone, over 5,482,602 people are currently…

  5. Journal Article Full text

    Targeting crucial host factors of SARS-CoV-2

    Tharappel, Anil Mathew; Samrat, Subodh Kumar; Li, Zhong et al.

    ACS Infect Dis · 2020 · English · PubMed Central

    COVID-19, caused by SARS-CoV-2, has spread worldwide since its first incident in Wuhan, China, in Dec 2019. Although the case fatality rate of COVID-19 appears to be lower than that of SARS and MERS, the higher transmissibility of SARS-CoV-2 has caused the total fatality to surpass other viral…

  6. Journal Article Full text

    Alternate Reading Frame Protein (F Protein) of Hepatitis C Virus: Paradoxical Effects of Activation and Apoptosis on Human Dendritic Cells Lead to Stimulation of T Cells

    Samrat, Subodh Kumar; Li, Wen; Singh, Shakti et al.

    PLoS One · 2014 · English · PubMed Central

    Hepatitis C virus (HCV) leads to chronic infection in the majority of infected individuals due to lack, failure, or inefficiency of generated adaptive immune responses. In a minority of patients, acute infection is followed by viral clearance. The immune correlates of viral clearance are not clear…

  7. Journal Article Full text

    Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection

    Jan Fada, Behdokht; Kaadi, Elie; Samrat, Subodh Kumar et al.

    J Virol · 2020 · English · PubMed Central

    ND10 nuclear bodies, as part of the intrinsic defenses, impose repression on incoming DNA. Infected cell protein 0 (ICP0), an E3 ubiquitin ligase of herpes simplex virus 1 (HSV-1), can derepress viral genes by degrading ND10 organizers to disrupt ND10. These events are part of the initial tug of…

  8. Journal Article Full text

    Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines

    Singh, Shakti; Vedi, Satish; Samrat, Subodh Kumar et al.

    PLoS One · 2016 · English · PubMed Central

    Adenoviruses (Ad) are commonly used as vectors for gene therapy and/or vaccine delivery. Recombinant Ad vectors are being tested as vaccines for many pathogens. We have made a surprising observation that peptides derived from various hepatitis C virus (HCV) antigens contain extensive regions of…

  9. Journal Article Full text

    An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease

    Samrat, Subodh Kumar; Kumar, Prashant; Liu, Yuchen et al.

    Viruses · 2024 · English · PubMed Central

    Emergence of newer variants of SARS-CoV-2 underscores the need for effective antivirals to complement the vaccination program in managing COVID-19. The multi-functional papain-like protease (PLpro) of SARS-CoV-2 is an essential viral protein that not only regulates the viral replication but also…

  10. Journal Article Full text

    The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

    Liang, Weifeng; Gu, Ming; Zhu, Lingxiang et al.

    Signal Transduct Target Ther · 2023 · English · PubMed Central

  11. Journal Article Full text

    Broad-spectrum small-molecule inhibitors targeting the SAM-binding site of flavivirus NS5 methyltransferase

    Samrat, Subodh Kumar; Bashir, Qamar; Huang, Yiding et al.

    ACS Infect Dis · 2023 · English · PubMed Central

    Flavivirus infections, such as those caused by dengue virus (DENV), West Nile virus (WNV), yellow fever virus (YFV), and Zika virus (ZIKV), pose a rising threat to global health. There are no FDA-approved drugs for flaviviruses, although a small number of flaviviruses have vaccines. For…

  12. Journal Article Full text

    Assay development and screening of inhibitors targeting the SARS-CoV-2 2′-O-methyltransferase NSP16

    Cao, Mengtong; Trieshmann, Carl W.; Samrat, Subodh Kumar et al.

    Pharm Sci Adv · 2025 · English · PubMed Central

    The coronavirus disease-2019 (COVID-19) pandemic, etiologically caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has profoundly impacted the global health. While vaccines have been developed, they have shown limited efficacy in treating patients already under infection or…

  13. Journal Article Full text

    In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus

    Li, Zhong; Xu, Jimin; Lang, Yuekun et al.

    Acta Pharm Sin B · 2021 · English · PubMed Central

    Zika virus (ZIKV) causes significant human diseases without specific therapy. Previously we found erythrosin B, an FDA-approved food additive, inhibited viral NS2B−NS3 interactions, leading to inhibition of ZIKV infection in cell culture. In this study, we performed pharmacokinetic and in vivo…

  14. Journal Article Full text

    A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases

    Samrat, Subodh Kumar; Bashir, Qamar; Zhang, Ran et al.

    Emerg Microbes Infect · 2023 · English · PubMed Central

    SARS-CoV-2 has caused a global pandemic with significant humanity and economic loss since 2020. Currently, only limited options are available to treat SARS-CoV-2 infections for vulnerable populations. In this study, we report a universal fluorescence polarization (FP)-based high throughput…

  15. Journal Article Full text

    Structure, function, and inhibition of adenylosuccinate lyase (ADSL) from Mycobacterium tuberculosis

    Singh, Vigyasa; Jaganathan, Devi; Corro, Jamie et al.

    ACS Infect Dis · 2025 · English · PubMed Central

    Adenylosuccinate lyase (ADSL), encoded by the purB gene, is an essential enzyme in the purine biosynthesis pathway of Mycobacterium tuberculosis (Mtb), making it a promising target for antimicrobial drug development. Here, we report the expression, purification, kinetic characterization…

  16. Journal Article Full text

    Allosteric inhibitors of the main protease of SARS-CoV-2

    Samrat, Subodh Kumar; Xu, Jimin; Xie, Xuping et al.

    Antiviral Res · 2022 · English · PubMed Central

    SARS-CoV-2 has raised the alarm to search for effective therapy for this virus. To date several vaccines have been approved but few available drugs reported recently still need approval from FDA. Remdesivir was approved for emergency use only. In this report, the SARS-CoV-2 3CLpro was expressed and…

  17. Journal Article Full text

    JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo

    Li, Zhong; Xu, Jimin; Lang, Yuekun et al.

    ACS Infect Dis · 2020 · English · PubMed Central

    Flaviviruses causes significant human disease. Recent outbreaks of the Zika virus highlight the need to develop effective therapies for this class of viruses. Previously we identified niclosamide as a broad-spectrum inhibitor for flaviviruses by targeting the interface between viral protease NS3…